•
BD
BDRX
Biodexa Pharmaceuticals plc American Depositary Shs
polygon--
Price Chart
Market Cap
1.85M
Volume
147.12K
52W High
$92.00
52W Low
$2.06
Open
$2.18
Prev Close
$2.21
Day Range
2.09 - 2.19
About Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Latest News
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
GlobeNewswire Inc.•Oct 29
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
GlobeNewswire Inc.•Oct 23
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Benzinga•Jul 12
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Benzinga
Benzinga•Jul 11
Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024
GlobeNewswire Inc.•Jul 2
Biodexa Announces Positive Phase 2 Clinical Trial Results of eRapaâ„¢ at 12 months in Familial Adenomatous Polyposis (FAP)
GlobeNewswire Inc.•Jun 24
Results of Annual General Meeting
GlobeNewswire Inc.•Jun 13
Twelve month Phase 2 Clinical Trial Results of eRapaâ„¢ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
GlobeNewswire Inc.•Jun 10